New England Journal of Medicine· 2015Q1
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- 2,613citations
- Q1SCImago
- 2015year
Short summary
A 56-week trial (n=3731) found 3.0 mg daily liraglutide injections, combined with lifestyle counseling, resulted in an average weight loss of 8.4 kg vs. 2.8 kg for placebo, with 63.2% losing at least 5% body weight vs. 27.1% for placebo.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Endocrinology, Diabetes and Metabolism
Endocrinology, Diabetes and MetabolismMedicine